Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2014

View Archived Issues

ApoE2 gene delivery reduces amyloid burden in the brain of transgenic mice

Genetic diversity affects susceptibility to Ebola virus infection

IOmet Pharma describes novel small-molecule GLUT-1 inhibitors for cancer

BioCryst reports data for BCX-4430 in model of Ebola virus infection

Elios Therapeutics' personalized cancer vaccine cleared for phase IIb testing

Cancer Research UK, CRT and Amgen to study AMG-319 in solid tumors

Roivant Neurosciences acquires SB-742457 from GlaxoSmithKline

Amarantus BioScience's Alzheimer's disease diagnostic available for use in clinical trials

Phylogica and Genentech enter antibacterial discovery collaboration

ADDC and AstraZeneca to support five high-throughput screening proposals

Endo Pharmaceuticals and BioDelivery Sciences submit NDA for Buprenorphine Buccal Film

BioCryst receives orphan drug designation for BCX-4161 for hereditary angioedema

Amarantus receives FDA orphan drug designation for MANF for retinitis pigmentosa

FDA approves supplemental BLA for Gazyva

Takeda submits NDA in Japan for glatiramer acetate

Takecab approved for the treatment of acid-related diseases in Japan

Chugai Pharmaceutical obtains approval of vemurafenib in Japan

Cosentyx approved in Japan for psoriasis and psoriatic arthritis

Vimizim approved in Japan for Morquio A syndrome

European approval for Xpert HIV-1 Viral Load test

Chiesi Farmaceutici patents MAPK 14 inhibitors

CSIR divulges silicon-containing antituberculosis pyrroles

Merck KGaA reports discovery of MST1R inhibitor

FDA approves use of Kalydeco for R117H mutation in cystic fibrosis

Data presented on a new chimeric antigen receptor targeting cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...